drugset / Trial / NCT00515879

Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia

NCT00515879

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the effectiveness of D-cycloserine combined with cognitive-behavior therapy in treating people with social anxiety disorder.

Timeline

Start
2007-12
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cycloserine Small molecule 50 mg

Indications